In vivo cII, gpt, and Spi- gene mutation assays in transgenic mice and rats

Methods in Molecular Biology

Volumn 1044, Issue , 2013, Pages 97-119

  Manjanatha, Mugimane G ^a   Cao, Xuefei ^a   Shelton, Sharon D ^a   Mittelstaedt, Roberta A ^a   Heflich, Robert H ^a  

^a NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH   (United States)

Author keywords

Big Blue ; cII; cII mutants; gpt mutants; gpt delta

Indexed keywords

DNA;

ARTICLE; BACTERIOPHAGE LAMBDA; CII GENE; GENE; GENE DELETION; GENE LOCUS; GENE MUTATION; GPT GENE; IN VIVO STUDY; METHODOLOGY; MUTATIONAL ANALYSIS; NONHUMAN; PRIORITY JOURNAL; SEQUENCE ANALYSIS; SPI GENE; TRANSGENIC MOUSE; TRANSGENIC RAT;

MUS; MUS MUSCULUS; RATTUS; RODENTIA;

EID: 84934437231     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-62703-529-3_5     Document Type: Article

References (6)

1. Lambert IB, Singer TM, Boucher SE et al (2005) Detailed review of transgenic rodent mutation assays. Mutat Res 590:1-280
2. Organization for Economic Cooperation and Development (OECD) (2011). OECD guideline for the testing of chemicals; transgenic rodent somatic and germ cell gene mutation assay. Available at: Http://www.oecd-ilibrary. org/docserver/download/fulltext/9748801e. pdf?expires=1342710912&id= id&accname=fre eContent&checksum=06A7713CC9C6E1B7E EFCC61F2565CD7
3. Pozniak A, Muller L, Salgo M et al (2009) Elevated EMS in nelfi navir mesylate (Viracept, Roche): Overview. AIDS Res Ther 6:18-23
4. Boverhof DR, Chamberlain MP, Elcombe CR et al (2011) Transgenic animal models in toxicology: Historical perspectives and future outlook. Toxicol Sci 121:207-233
5. Heddle JA, Martus HJ, Douglas GR (2003) Treatment and sampling protocols for transgenic mutation assays. Environ Mol Mutagen 41:1-6
6. Thybaud V, Dean S, Nohmi T et al (2003) In vivo transgenic mutation assays. Mutat Res 540:141-151